Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer.

Allen TD, Zhu CQ, Jones KD, Yanagawa N, Tsao MS, Bishop JM.

Cancer Res. 2011 Mar 15;71(6):2212-21. doi: 10.1158/0008-5472.CAN-10-3590.

2.

Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.

Kren L, Brazdil J, Hermanova M, Goncharuk VN, Kallakury BV, Kaur P, Ross JS.

Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):44-9. Review.

PMID:
15163019
3.

Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors.

Guo JY, White E.

Autophagy. 2013 Oct;9(10):1636-8. doi: 10.4161/auto.26123. Epub 2013 Aug 15. Review.

PMID:
23959381
4.

Programming cancer cells for high expression levels of Mcl1.

Ertel F, Nguyen M, Roulston A, Shore GC.

EMBO Rep. 2013 Apr;14(4):328-36. doi: 10.1038/embor.2013.20. Epub 2013 Mar 12. Review.

5.

Emerging roles of DMP1 in lung cancer.

Inoue K, Sugiyama T, Taneja P, Morgan RL, Frazier DP.

Cancer Res. 2008 Jun 15;68(12):4487-90. doi: 10.1158/0008-5472.CAN-07-6791. Review.

6.

Biology and treatment of myeloma.

Brioli A, Melchor L, Walker BA, Davies FE, Morgan GJ.

Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S65-70. doi: 10.1016/j.clml.2014.06.011. Review.

PMID:
25486959
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk